In Vitro Activities of a New Des-Fluoro(6) Quinolone, Garenoxacin, against Clinical Anaerobic Bacteria

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 11, 2003, Pages 3667-3671

  Liebetrau, A ^a   Rodloff, A C ^a   Behra Miellet, J ^b   Dubreuil, L ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GARENOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM; BILOPHILA WADSWORTHIA; CLOSTRIDIUM DIFFICILE; DILUTION; FUSOBACTERIUM; GRAM POSITIVE COCCI; NONHUMAN; PORPHYROMONAS; PREVOTELLA; PRIORITY JOURNAL; PROPIONIBACTERIUM; VEILLONELLA;

ANTI-INFECTIVE AGENTS; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; BETA-LACTAMASES; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0242353916     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.11.3667-3671.2003     Document Type: Article

References (31)

1. Acar, J., G. Carret, J. D. Cavallo, H. Chardon, P. Choutet, P. Courvalin, H. Dabernat, H. Drugeon, L. Dubreuil, F. Goldstein, V. Jarlier, R. Leclercq, M. H. Nicolas-Chanoine, A. Philippon, B. Rouveix, J. Sirot, C. J. Soussy, and A. Thabaut. 1998. Communiqué de l'antibiogramme de la Société Française de Microbiologie. Valeurs critiques pour l'antibiogramme. Pathol. Biol. 46: 1-16.
2. Ackermann, G., R. Schaumann, B. Pless, M. C. Claros, E. J. C. Goldstein, and A. C. Rodloff. 2000. Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria. Eur. J. Microbiol. Infect. Dis. 19:228-232.
3. Ackermann, G., Y. J. Tang, R. Kueper, P. Heisig, A. C. Rodloff, J. Silva, Jr., and S. H. Cohen. 2001. Resistance to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutations in gyrA. Antimicrob. Agents Chemother. 45:2348-2353.
4. Ackermann, G., Y. Tang, A. C. Rodloff, J. Silva, Jr., S. H. Cohen, and P. Heisig. 2001. In vitro activity of sitafloxacin against Clostridium difficile. J. Antimicrob. Chemother. 47:722-723.
5. Aldridge, K. E., D. Ashcraft, K. Cambre, C. L. Pierson, S. G. Jenkins, and J. E. Rosenblatt. 2001. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob. Agents Chemother. 45:1238-1243.
6. Bassetti, M., L. M. Dembry, P. A. Farrel, D. A. Callan, and V. T. Andriole. 2002. Antimicrobial activities of BMS-284756 compared with those of fluoroquinolones and β-lactams against gram-positive clinical isolates. Antimicrob. Agents Chemother. 46:234-238.
7. Bauernfeind, A. 1993. Comparative in vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosafloxacin, CI-960 and CI-990. J. Antimicrob. Chemother. 31:505-522.
8. Bauernfeind, A. 1997. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J. Antimicrob. Chemother. 40:639-651.
9. Betriu, C., M. Gómez, M. L. Palau, A. Sánchez, and J. J. Picazo. 1999. Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents. Antimicrob. Agents Chemother. 43:2320-2322.
10. Dubreuil, L., J. Breuil, A. Dublanchet, and A. Sedallian. 1992. Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992. Eur. J. Clin. Microbiol. Infect. Dis. 11:1094-1099.
11. Ednie, L. M., R. Jacobs, and P. C. Appelbaum. 1998. Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms. Antimicrob. Agents Chemother. 42:2459-2462.
12. Fix, A. M., M. A. Pfaller, D. J. Biedenbach, M. L. Beach, and R. N. Jones. 2001. Comparative antimicrobial spectrum and activity of BMS284756 (T-3811, a desfluoroquinolone) tested against 656 enterobacteriaceae, including preliminary in vitro susceptibility test comparisons and development. Int. J. Antimicrob. Agents 18:141-145.
13. Fung-Tomc, J. C., B. Minassian, B. Kolek, E. Huczko, L. Aleksunes, T. Stickle, T. Washo, E. Gradelski, L. Valera, and D. P. Bonner. 2000. Antibacterial spectrum of a novel des-fluoro(6) quinolone, BMS-284756. Antimicrob. Agents Chemother. 44:3351-3356.
14. Goldstein, E. J. C., and D. M. Citron. 1992. Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and Win 57273 against anaerobic bacteria. Antimicrob. Agents Chemother. 36:1158-1162.
15. Goldstein, E. J. C., D. M. Citron, C. V. Merriam, Y. A. Warren, K. L. Tyrrell, and H. Fernandez. 2002. In vitro activities of the des-fluoro(6) quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections. Antimicrob. Agents Chemother. 46:866-870.
16. Grollier, G., F. Mory, C. Quentin, F. Girard-Pipau, S. Tigaud, A. Sedallian, and L. Dubreuil. 1994. Survey of anaerobic susceptibility patterns: a French multicentric study. Pathol. Biol. 42:498-504.
17. Hoellman, D. B., L. M. Kelly, M. R. Jacobs, and P. C. Appelbaum. 2001. Comparative antianaerobic activity of BMS 284756. Antimicrob. Agents Chemother. 45:589-592.
18. Jousimies-Somer, H. R., P. Summanen, D. M. Citron, E. J. Baron, H. M. Wexler, and S. M. Finegold. 2002. Wadsworth anaerobic bacteriology manual, 6th ed. Star Publishing Co., Belmont, Calif.
19. Lubbe, M. M., P. L. Botha, and L. J. Chalkley. 1999. Comparative activity of eighteen antimicrobial agents against anaerobic bacteria isolated in South Africa. Eur. Clin. Microbiol. Infect. Dis. 18:46-54.
20. Mory, F., A. Loczniewski, S. Bland, A. Sedallian, G. Grollier, F. Girard-Pipau, M. F. Paris, and L. Dubreuil. 1998. Survey of anaerobic susceptibility patterns: a French multicentric study. Int. J. Antimicrob. Agents 10:229-236.
21. Nagy, E., J. Sóki, E. Urbán, I. Szöke, E. Fodor, and R. Edwards. 2001. Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary. Acta Biol. Hung. 52:271-280.
22. NCCLS. 2001. Methods for antimicrobial testing of anaerobic bacteria, fifth edition. Approved standard M11-A5. NCCLS, Wayne, Pa.
23. Patey, O., E. Varon, I. Podglajen, A. Dublanchet, L. Dubreuil, and J. Breuil. 1994. Multicentre survey in France of the antimicrobial susceptibilities of 416 blood culture isolates of the Bacteroides fragilis group. J. Antimicrob. Chemother. 33:1029-1034.
24. Pfaller, M. A., M. L. Beach, K. A. Gordon, and R. N. Jones. 2002. Comparative antimicrobial spectrum and activity of BMS284756 (T-3811; a desfluoroquinolone) tested against an international collection of staphylococci and enterococci, including in vitro test development and intermethod comparison. J. Chemother. 14:13-18.
25. Rhomberg, P. R., D. J. Biedenbach, and R. N. Jones. 2001. Activity of BMS284756 (T-3811) tested against anaerobic bacteria, Campylobacter jejuni, Helicobacter pylori and Legionella spp. Diagn. Microbiol. Infect. Dis. 40:45-49.
26. Schaumann, R., G. Ackermann, B. Pless, M. C. Claros, and A. C. Rodloff. 1999. In vitro activities of gatifloxacin, two other quinolones, and five non-quinolone antibimicrobials against obligately anaerobic bacteria. Antimicrob. Agents Chemother. 43:2783-2786.
27. Snydman, D. R., N. V. Jacobus, L. A. McDermott, S. Supran, G. J. Cuchural, Jr., S. Finegold, L. Harrell, D. W. Hecht, P. Iannini, S. Jenkins, C. Pierson, J. Rihs, and S. L. Gorbach. 1999. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antimicrob. Agents Chemother. 43:2417-2422.
28. Spangler, S. K., M. R. Jacobs, and P. C. Appelbaum. 1994. Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes. Antimicrob. Agents Chemother. 38:2471-2476.
29. Takahata, M., J. Mitsuyama, Y. Yamashiro, M. Yonezawa, H. Araki, Y. Todo, S. Minami, Y. Watanabe, and H. Narita. 1999. In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone. Antimicrob. Agents Chemother. 43:1077-1084.
30. Weller, T. M. A., J. M. Andrews, G. Jevons, and R. Wise. 2002. The in vitro activity of BMS-284756, a new des-fluorinated quinolone. J. Antimicrob. Chemother. 49:177-184.
31. Wexler, H. M., E. Molitoris, D. Molitoris, and S. M. Finegold. 1996. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria. Antimicrob. Agents Chemother. 40:2232-2235.